Ranger Investment Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.2M | Sell |
26,869
-21,488
| -44% | -$9.92M | 0.9% | 48 |
|
|
2026
Q1 | $23.2M | Sell |
48,357
-360
| -0.7% | -$184K | 1.68% | 20 |
|
|
2025
Q4 | $27.4M | Sell |
48,717
-158
| -0.3% | -$89.7K | 1.88% | 16 |
|
|
2025
Q3 | $25.1M | Sell |
48,875
-18,872
| -28% | -$8.24M | 1.75% | 24 |
|
|
2025
Q2 | $21.3M | Sell |
67,747
-3,665
| -5% | -$1.1M | 1.48% | 30 |
|
|
2025
Q1 | $21.8M | Sell |
71,412
-1,064
| -1% | -$358K | 1.56% | 27 |
|
|
2024
Q4 | $24.1M | Sell |
72,476
-1,595
| -2% | -$541K | 1.52% | 28 |
|
|
2024
Q3 | $24.7M | Sell |
74,071
-44,312
| -37% | -$16.8M | 1.59% | 31 |
|
|
2024
Q2 | $48.8M | Sell |
118,383
-1,530
| -1% | -$606K | 3.32% | 4 |
|
|
2024
Q1 | $48.5M | Sell |
119,913
-18,831
| -14% | -$6.62M | 3.12% | 3 |
|
|
2023
Q4 | $42.5M | Sell |
138,744
-50,958
| -27% | -$13.8M | 2.58% | 6 |
|
|
2023
Q3 | $45.9M | Sell |
189,702
-6,926
| -4% | -$1.77M | 3.05% | 5 |
|
|
2023
Q2 | $47.2M | Buy |
196,628
+5,960
| +3% | +$1.24M | 2.84% | 6 |
|
|
2023
Q1 | $35.9M | Buy |
190,668
+11,265
| +6% | +$2.33M | 2.4% | 15 |
|
|
2022
Q4 | $38.1M | Sell |
179,403
-22,608
| -11% | -$4.52M | 2.83% | 8 |
|
|
2022
Q3 | $31.8M | Sell |
202,011
-108,721
| -35% | -$17.3M | 2.49% | 13 |
|
|
2022
Q2 | $46.5M | Sell |
310,732
-6,170
| -2% | -$893K | 3.52% | 5 |
|
|
2022
Q1 | $51.8M | Buy |
316,902
+8,200
| +3% | +$1.35M | 3.28% | 3 |
|
|
2021
Q4 | $67.2M | Sell |
308,702
-22,271
| -7% | -$4.66M | 3.67% | 3 |
|
|
2021
Q3 | $62.6M | Sell |
330,973
-8,955
| -3% | -$1.63M | 3.34% | 3 |
|
|
2021
Q2 | $60M | Sell |
339,928
-7,936
| -2% | -$1.37M | 3.13% | 3 |
|
|
2021
Q1 | $57.1M | Sell |
347,864
-36,638
| -10% | -$5.6M | 3.14% | 4 |
|
|
2020
Q4 | $53.5M | Sell |
384,502
-12,951
| -3% | -$1.63M | 2.82% | 6 |
|
|
2020
Q3 | $44.4M | Sell |
397,453
-2,810
| -0.7% | -$325K | 2.83% | 9 |
|
|
2020
Q2 | $37.2M | Sell |
400,263
-35,893
| -8% | -$3.05M | 2.55% | 13 |
|
|
2020
Q1 | $32M | Buy |
436,156
+103,591
| +31% | +$8.99M | 2.82% | 8 |
|
|
2019
Q4 | $28M | Buy |
332,565
+94,274
| +40% | +$7.3M | 1.84% | 24 |
|
|
2019
Q3 | $20M | Sell |
238,291
-104,104
| -30% | -$7.87M | 1.44% | 36 |
|
|
2019
Q2 | $22.4M | Sell |
342,395
-3,220
| -0.9% | -$186K | 1.53% | 29 |
|
|
2019
Q1 | $20.4M | Buy |
345,615
+136,026
| +65% | +$8.13M | 1.47% | 33 |
|
|
2018
Q4 | $11.1M | Buy |
+209,589
| New | +$11.5M | 0.9% | 44 |
|
Other funds holding MEDP
WA
Ranger Investment Management's MEDP Position: Q2 2026 in Review
Ranger Investment Management reduced its Medpace (MEDP) stake by 44% in Q2 2026, selling an estimated $9.92M and leaving 26,869 shares worth $14.2M. The position accounts for 0.9% of the portfolio, ranked #48.
Ranger Investment Management first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $67.2M in Q4 2021. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Ranger Investment Management held 26,869 shares of Medpace worth $14.2M as of Q2 2026.
- Ranger Investment Management sold 21,488 Medpace shares in Q2 2026, an estimated $9.92M.
- Medpace made up 0.9% of Ranger Investment Management's portfolio in Q2 2026, its #48 holding.
- Ranger Investment Management first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- Ranger Investment Management's Medpace position peaked at $67.2M in Q4 2021.
- 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Ranger Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.